OptiMedical’s critical care business is focused on portable instruments for measurement of time sensitive diagnostics tests such as blood gas, electrolyte and metabolite analysis. The OPTI product line has established market positions throughout the world with an existing customer base of over 5,000 instruments already in use, with approximately one-third in the US. Revenue is generated through sales of new instruments and ongoing repeat sales of proprietary reagents to facilitate analysis. OPTI Medical Systems employs an experienced team of about 90 employees

The OPTI analyzers utilize a sensor technology based on optical fluorescence sensors and the process of optical reflectance. The major advantages of this technology are its reliability and stability, which makes the technology superior to electrochemical based systems.